BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
10 results:

  • 1. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
    Dodin Y
    Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and treatment Options.
    Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study.
    Srisongkram T; Weerapreeyakul N
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614109
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis and survival.
    Righi A; Pacheco M; Cocchi S; Asioli S; Gambarotti M; Donati DM; Evangelista A; Gnoli M; Locatelli M; Mordenti M; Boarini M; Brizola E; Pedrini E; Sangiorgi L
    Orphanet J Rare Dis; 2022 Feb; 17(1):74. PubMed ID: 35193636
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
    Singh TP; Sharma A; Sharma A; Bakhshi S; Patel C; Pandey AK; Dhamija E; Batra A; Kumar R
    Nucl Med Commun; 2021 Jul; 42(7):818-825. PubMed ID: 33741856
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pencil beam scanned protons for the treatment of patients with Ewing sarcoma.
    Weber DC; Murray FR; Correia D; Bolsi A; Frei-Welte M; Pica A; Lomax AJ; Schneider R; Bachtiary B
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28627000
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
    Avigad S; Shukla S; Naumov I; Cohen IJ; Ash S; Meller I; Kollender Y; Issakov J; Yaniv I
    Pediatr Blood Cancer; 2009 Dec; 53(6):1023-8. PubMed ID: 19637319
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Enhanced biological activity of human recombinant interleukin 2 coupled to mouse red blood cells as evaluated using the mouse Meth A sarcoma model.
    Moyes RB; Kirch H; DeLoach JR
    Biotechnol Appl Biochem; 1996 Feb; 23(1):29-36. PubMed ID: 8867894
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma. Long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia.
    Alonso K; Pontiggia P; Sabato A; Calvi G; Curto FC; de Bartolomei E; Nardi C; Cereda P
    Am J Clin Oncol; 1994 Aug; 17(4):353-9. PubMed ID: 7914057
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.